Search

Your search keyword '"Hollander, P"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Hollander, P" Remove constraint Author: "Hollander, P" Database Unpaywall Remove constraint Database: Unpaywall
73 results on '"Hollander, P"'

Search Results

1. SOLUBLE MACROPHAGE MARKER SCD163 PREDICTS OUTCOME IN BOTH CHEMOIMMUNOTHERAPY AND TARGETED THERAPY TREATED MANTLE CELL LYMPHOMA

4. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

8. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth

10. Evaluation of immunogenicity of LY2963016 insulin glargine compared with L antus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

11. Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the ELEMENT 2 study)

12. Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapy

14. P336 Efficacité et tolérance de la canagliflozine chez des diabétiques de type 2 (DT2) mal contrôlés par metformine plus sulfamide hypoglycémiant sur une période de 52 semaines

16. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

18. Efficacité et tolérance de l’insuline dégludec administrée selon un schéma flexible versus insuline dégludec ou insuline glargine administrées selon un schéma fixe dans le diabète de type 1 : résultats de l’essai « BEGIN: Flex T1 », un essai randomisé en treat-to-target de 26 semaines, et de son extension à 52 semaines

21. O37 L’insuline dégludec comparée à l’insuline glargine diminue le nombre d’épisodes d’hypoglycémie nocturne: résultats à 1 an des essais randomisés en basal-bolus chez des diabétiques de type 1 (DT1) et de type 2 (DT2)

24. A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

Catalog

Books, media, physical & digital resources